Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> F >> trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene

trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene
[CAS# 136922-40-2]

List of Suppliers
Beijing Bayi Space LCD Technology Co., Ltd. China Inquire  
+86 (10) 6976-5588 ex 8068
+86 18600516188
zhangshupo@aliyun.com
QQ chat
Chemical manufacturer since 2004
Complete supplier list of trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene
Identification
Name trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene
Molecular Structure CAS # 136922-40-2, trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene
Molecular Formula C23H29F
Molecular Weight 324.47
CAS Registry Number 136922-40-2
Properties
Solubility Insoluble (2.4E-6 g/L) (25 ºC), Calc.*
Density 1.006±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2014 ACD/Labs)
Market Analysis Reports
List of Reports Available for trans-1-[2-(4-Fluorophenyl)ethyl]-4-(4-propylcyclohexyl)benzene
Related Products
1-[2-(4-Fluorophenyl)ethyl]-alpha-(3-hydroxy-2-methoxyphenyl)-4-piperidinemethanol  (alphaR)-1-[2-(4-Fluorophenyl)ethyl]-alpha-(3-hydroxy-2-methoxyphenyl)-4-piperidinemethanol  (E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one  1-[2-(4-Fluorophenyl)ethyl]piperazine  1-[1-(4-Fluorophenyl)ethyl]piperazine hydrochloride  1-[1-(4-Fluorophenyl)ethyl]-4-piperidinamine hydrochloride  N-[1-(4-Fluorophenyl)ethyl]-3-piperidinemethanamine hydrochloride  N-[1-(4-Fluorophenyl)ethyl]-4-piperidinemethanamine hydrochloride  1-[1-(4-Fluorophenyl)ethyl]-4-piperidinol  4-[2-(4-Fluorophenyl)ethyl]-4'-propyl-1,1'-biphenyl  [(3-Fluorophenyl)ethynyl]trimethylsilane  (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-(phenylmethoxy)phenyl]methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone  (1S)-1-(4-Fluorophenyl)-3-[(2S,3R)-1-(4-fluorophenyl)-2-(4-hydroxyphenyl)-4-oxo-3-azetidinyl]propyl beta-D-glucopyranosiduronic acid  (3R,4S)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3S,4R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3S,4R)-rel-1-(4-Fluorophenyl)-3-[(3R)-3-(2-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3S,4R)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone  (3R,4S)-1-(3-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone